Clinical Outcomes of Patients with C3G or IC-MPGN Treated with the Factor D Inhibitor Danicopan: Final Results from Two Phase 2 Studies von Nester, Carla, Appel, Gerald B., Bomback, Andrew S., Bouman, Koenraad Peter, Cook, H. Terence, Daina, Erica, Dixon, Bradley P., Rice, Kara, Najafian, Nader, Hui, James, Podos, Steven D., Langman, Craig B., Lightstone, Liz, Parikh, Samir V., Pickering, Matthew C., Sperati, C. John, Trachtman, Howard, Tumlin, James, de Vries, Aiko PJ, Wetzels, Jack F.M., Remuzzi, Giuseppe

Volltext

Baseline Clinical Characteristics and Complement Biomarkers of Patients with C3 Glomerulopathy Enrolled in Two Phase 2 Studies Investigating the Factor D Inhibitor Danicopan von Podos, Steven D., Trachtman, Howard, Appel, Gerald B., Bomback, Andrew S., Dixon, Bradley P., Wetzels, Jack F.M., Cook, H. Terence, Parikh, Samir V., Pickering, Matthew C., Tumlin, James, Langman, Craig B., Lightstone, Liz, Sperati, C. John, Daina, Erica, Bouman, Koenraad Peter, Rice, Kara, Thanassi, Jane A., Huang, Mingjun, Nester, Carla, Remuzzi, Giuseppe

Volltext